# Nano MRI on 7 Tesla in Rectal and Breast Cancer

> **NCT02751606** · PHASE3 · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Rectal Neoplasms
- Breast Neoplasms

## Interventions

- **DRUG:** ferumoxtran-10
- **DEVICE:** 7 Tesla MRI
- **DEVICE:** 3 Tesla MRI

## Key facts

- **NCT ID:** NCT02751606
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2019-06
- **Final completion:** 2019-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02751606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02751606, "Nano MRI on 7 Tesla in Rectal and Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02751606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*